Accueil › Cancer du poumon non à petites cellules › Arkansas › Springdale
Essais cliniques pour Cancer du poumon non à petites cellules à Springdale, AR
15 études pour Cancer du poumon non à petites cellules recherchent des participants dans et autour de Springdale (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Recrutement en coursPhase 2/3
- Highlands Oncology Group - Springdale /ID# 277132, Springdale
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Recrutement en coursPhase 3
- Highlands Oncology Group, PA, Springdale
- Highlands Oncology Group, Springdale
- Highlands Oncology Group, PA, Rogers · à 10 mi
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Recrutement en coursPhase 3
- Highlands Oncology Group-Research Department ( Site 0062), Springdale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Highlands Oncology Group, Springdale
- Highlands Oncology Group, Rogers · à 10 mi
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Recrutement en coursPhase 1/2
- Highlands Oncology Group, PA, Springdale
- Highlands Oncology Group, PA, Rogers · à 10 mi
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Highlands Oncology Group, Springdale
Pan-tumor MRD Study
Recrutement en coursÉtude observationnelle
- Highlands Oncology Group (HOG), Springdale
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Recrutement en coursPhase 3
- Research Site, Springdale
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Recrutement en coursPhase 3
- Local Institution - 0686, Springdale
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Recrutement en coursPhase 3
- Research Site, Springdale
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Recrutement en coursPhase 2/3
- Highlands Oncology Group - Springdale, Springdale
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Highlands Oncology Group, Springdale
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
Recrutement en coursPhase 3
- Highlands Oncology Group, Springdale
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Recrutement en coursPhase 1
- Highlands Oncology Group, Springdale
- Highlands Oncology Group, Rogers · à 10 mi
BostonGene and Exigent Genomic INsight Study
Recrutement en coursÉtude observationnelle
- Highlands Oncology Group, Rogers · à 10 mi
Essais pour Cancer du poumon non à petites cellules dans d'autres villes
- Houston, TX145 études
- New York City, NY120 études
- Arlington, VA104 études
- Nashville, TN97 études
- Boston, MA90 études
- Los Angeles, CA87 études
- St. Louis, MO73 études
- Chicago, IL61 études
- Baltimore, MD60 études
- San Antonio, TX59 études
- Columbus, OH56 études
- Washington, DC55 études
Autres études à Springdale
- Schizophrénie7 études
- Cancer du poumon6 études
- Cancer métastatique6 études
- Cancer du sein5 études
- Cancer (tous types)5 études
- Trouble dépressif majeur5 études
- Cancer colorectal5 études
- Dépression4 études
- Cancer de la vessie4 études
- Carcinome épidermoïde de la tête et du cou3 études
- Myélome multiple3 études
- Cancer bronchique à petites cellules3 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.